Sofie Biosciences

Introducing GENISYS⁴
A new generation of PET.

GENISYS⁴ breaks away from a conventional ring-based system by surrounding the animal with panel detectors.
This architecture results in the most sensitive PET system ever built.

This sensitivity allows you to image trace amounts of probes, which translates
to 10x less dose to the animal and 10x less dose to the researcher, all while
maintaining beautiful image quality.

A breakthrough class of PET imaging probes providing in vivo diagnostic assays to researchers and clinicians in the fields of oncology and immunology.

Sofie’s family of proprietary PET probes, ¹⁸F-FAC and analogs, provide information previously not possible with existing measurement or imaging techniques. With this novel diagnostic, investigators are now able to examine a class of biological processes in oncology, immunology, and pharmacology. From quantifying the level and spatial distribution of immune cell activation in vivo, to investigating the stratification of nucleoside prodrug treatment in cancer patients, ¹⁸F-FAC enhances your existing oncology and immunology research.

Reduce complexity and increase flexibility with ELIXYS™, Sofie Biosciences’ automated modular radiochemistry unit.

You asked for a streamlined, easy-to-use radiosynthesis platform to produce a diversity of imaging probes and we listened. ELIXYS’ automated, modular design provides versatility while maintaining simplicity. Configure your system to act as a workhorse for routine production, or plug-and-play with various modules to expand its capability for new probe development. In either case, those new and old to probe synthesis can answer the call to produce an increasing diversity of PET biomarkers.